Clinical Trials Directory

Trials / Completed

CompletedNCT03510910

Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this proposed study is to evaluate the efficacy of a multimodal approach to analgesia for patient's pain after hip arthroscopy and to also assess if this new approach will result in a reduction in post-operative narcotic use. This study is a single-center, randomized prospective study comparing post-operative pain scores and narcotic consumption between individuals receiving acetaminophen along with a reduced quantity of Percocet (to be used as needed for breakthrough pain) and individuals receiving Percocet only. Both pain management options are considered to be standard of care. Both cohorts will receive aspirin for DVT prophylaxis and celecoxib for heterotopic ossification prophylaxis. The primary objective of the study are to compare patients' narcotic consumption and reported pain following arthroscopic hip surgery, and determine if acetaminophen can provide adequate pain relief compared to a narcotic medication.

Conditions

Interventions

TypeNameDescription
DRUGAcetaminophenacetaminophen 600 mg to be taken every 8 hours (TID)
DRUGPercocetOxycodone/acetaminophen (Percocet) 5 mg/325 mg as needed for breakthrough pain for patients in Percocet+ Acetaminophen group. Percocet Group will receive standard of care Percocet 5 mg/325 mg every 6 hours PRN

Timeline

Start date
2018-04-10
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2018-04-27
Last updated
2021-01-07
Results posted
2021-01-07

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03510910. Inclusion in this directory is not an endorsement.